Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
1,216
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection

Lunzhi YuanState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Xuan LiuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Liang ZhangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Yali ZhangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Yao ChenState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Xiaoling LiState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Kun WuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Jiali CaoState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Wangheng HouState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Yuqiong QueState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Jun ZhangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. China
,
Hua ZhuDepartment of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical SchoolRutgers University 225 Warren Street 070101NewarkNJUSA
,
Quan YuanState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. ChinaCorrespondence[email protected]
,
Qiyi TangDepartment of MicrobiologyHoward University College of Medicine20059WashingtonDCUSACorrespondence[email protected]
,
Tong ChengState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. ChinaCorrespondence[email protected]
&
Ningshao XiaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Science, School of Public HealthXiamen University361102XiamenP. R. ChinaORCID Iconhttp://orcid.org/0000-0003-0179-5266
ORCID Icon show all
Pages 1-17 | Received 01 May 2018, Accepted 06 Jul 2018, Published online: 10 Aug 2018

Related Research Data

Stem cell-derived hepatocytes: A promising novel tool to study hepatitis B virus infection.
Source: Elsevier BV
A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
Source: Elsevier BV
Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.
Source: BMJ
Sleeping Beauty transposon-based system for rapid generation of HBV-replicating stable cell lines
Source: Elsevier BV
Direct Cytopathic Effects of Particular Hepatitis B Virus Genotypes in Severe Combined Immunodeficiency Transgenic With Urokinase-Type Plasminogen Activator Mouse With Human Hepatocytes
Source: Elsevier BV
VIRAL HEPATITIS
Source: Wiley
Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.
Source: Microbiology Society
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.
Source: HAL CCSD
Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
Source: Wiley
In vitro model for the prediction of clinical CYP3A4 induction using HepaRG cells
Source: Informa UK Limited
A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection.
Source: Frontiers Media SA
The histone deacetylase inhibiting drug Entinostat induces lipid accumulation in differentiated HepaRG cells.
Source: Springer Science and Business Media LLC
New horizons for studying human hepatotropic infections.
Source: American Society for Clinical Investigation
Experimental models of hepatitis B and C — new insights and progress
Source: Springer Science and Business Media LLC
Infection of a human hepatoma cell line by hepatitis B virus
Source: Proceedings of the National Academy of Sciences
Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA Formation
Source: American Society for Microbiology
Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes
Source: Informa UK Limited
A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.
Source: Elsevier BV
Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors
Source: Elsevier BV
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Source: Elsevier BV
Selective extraction of polyoma DNA from infected mouse cell cultures.
Source: Elsevier BV
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.